Browse Colorectal cancer topic

Patient outcomes subtopic

Articles 1-16 out of 16 article(s) Title Author Type Date Words Moderate exercise boosts survival rates for colorectal cancer patients. Dec 15, 2009 221 Evolution of multidisciplinary care for patients with metastatic colorectal cancer: the 'win-win' combination of surgery and chemotherapy. Adam, Rene; Gorden, D. Lee Clinical report Jun 1, 2009 988 Colorectal carcinoma: selected issues in pathologic examination and staging and determination of prognostic factors. Report Mar 1, 2009 238 ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced. Aug 29, 2008 2114 Study Suggests Survival Benefit from Radioactive Microsphere Therapy in Patients with Colorectal Cancer Liver Metastases who have Failed Chemotherapy. Clinical report Jun 2, 2008 1087 Anti-angiogenic agents in colorectal cancer. Guillen-Ponce, Carmen; Carrato, Alfredo Report Jun 1, 2008 4806 ERBITUX(R) (Cetuximab) Data Demonstrate Improved Overall Survival in First-Line Treatment of Advanced Non-Small Cell Lung Cancer. Clinical report May 31, 2008 2583 DNA Modification Seen in Colorectal Tumors Helps Predict Outcomes, John Wayne Cancer Institute Researchers Find. May 21, 2008 702 ERBITUX(R) (cetuximab) Data Demonstrate Improvements in Response Rate and Progression-Free Survival in Wild Type K-Ras Metastatic Colorectal Cancer Patients in First-Line Setting. Clinical report May 16, 2008 1505 Pro-Pharmaceuticals DAVANAT(R) Extends Median Survival 6.7 Months for End-Stage Colorectal Cancer Patients After All Other Treatments Failed. Mar 3, 2008 1164 New Data Shows DAVANAT(R) Extends Survival of End-Stage Colorectal Cancer Patients More Than 6 Months. Feb 11, 2008 982 KRAS Gene Status May Impact Vectibix(TM) (Panitumumab) Efficacy and Patient Reported Outcomes in Advanced Colorectal Cancer Patients. Jan 24, 2008 2040 Cetuximab in elderly patients. Bachet, Jean Baptiste; Bouchahda, Mohamed; Mitry, Emmanuel; Cudennec, Tristan; Vaillant, Jean Nicola Clinical report Dec 1, 2007 1813 Randomized Phase III Trial Showed ERBITUX Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients. Clinical report Apr 16, 2007 2452 Surveillance of the colorectal cancer disparities among demographic subgroups: a spatial analysis. Lai, Dejian Sep 1, 2006 5680 ERBITUX(R) Data on Locoregional Control and Overall Survival in Phase III Head and Neck Cancer Study Presented at AACR-NCI-EORTC Meeting. Nov 16, 2005 1487